Denise Dignam M.'s most recent trade in Chemours Company was a trade of 4,068 Common Stock done at an average price of $12.1 . Disclosure was reported to the exchange on Aug. 8, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Chemours Company | Denise M. Dignam | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 12.06 per share. | 08 Aug 2025 | 4,068 | 191,546 (0%) | 0% | 12.1 | 49,060 | Common Stock |
| Chemours Company | Denise M. Dignam | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.50 per share. | 01 Aug 2025 | 466 | 187,478 (0%) | 0% | 11.5 | 5,359 | Common Stock |
| Kulicke & Soffa Industries... | Denise M. Dignam | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 1,260 | 8,572 (0%) | 0% | 0 | Common Stock | |
| Kulicke & Soffa Industries... | Denise M. Dignam | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 1,343 | 7,312 (0%) | 0% | 0 | Common Stock | |
| Chemours Company | Denise M. Dignam | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 367,866 | 367,866 | - | - | Stock Option (Right to Buy) | |
| Chemours Company | Denise M. Dignam | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 353,717 | 353,717 | - | - | Stock Option (Right to Buy) | |
| Chemours Company | Denise M. Dignam | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 106,421 | 177,211 (0%) | 0% | 0 | Common Stock | |
| Chemours Company | Denise M. Dignam | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.95 per share. | 01 Mar 2025 | 4,818 | 70,790 (0%) | 0% | 14.9 | 72,029 | Common Stock |
| Kulicke & Soffa Industries... | Denise M. Dignam | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 956 | 5,969 (0%) | 0% | 0 | Common Stock | |
| Kulicke & Soffa Industries... | Denise M. Dignam | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2024 | 1,025 | 5,013 (0%) | 0% | 0 | Common Stock | |
| Chemours Company | Denise M. Dignam | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.31 per share. | 01 Aug 2024 | 303 | 75,608 (0%) | 0% | 23.3 | 7,063 | Common Stock |
| Kulicke & Soffa Industries... | Denise M. Dignam | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 933 | 3,988 (0%) | 0% | 0 | Common Stock | |
| Chemours Company | Denise M. Dignam | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2024 | 95,792 | 95,792 | - | - | Performance Stock Option (Right to Buy) | |
| Chemours Company | Denise M. Dignam | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2024 | 92,108 | 92,108 | - | - | Stock Option (Right to Buy) | |
| Chemours Company | Denise M. Dignam | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2024 | 34,431 | 75,327 (0%) | 0% | 0 | Common Stock | |
| Kulicke & Soffa Industries... | Denise M. Dignam | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2024 | 891 | 3,055 (0%) | 0% | 0 | Common Stock | |
| Chemours Company | Denise M. Dignam | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2024 | 9,496 | 43,954 (0%) | 0% | 0 | Common Stock | |
| Chemours Company | Denise M. Dignam | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 28.88 per share. | 27 Mar 2024 | 3,058 | 40,896 (0%) | 0% | 28.9 | 88,315 | Common Stock |
| Chemours Company | Denise M. Dignam | Interim CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.78 per share. | 01 Mar 2024 | 1,299 | 34,229 (0%) | 0% | 20.8 | 26,993 | Common Stock |
| Kulicke & Soffa Industries... | Denise Dignam M. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 853 | 2,164 (0%) | 0% | 0 | Common Stock | |
| Kulicke & Soffa Industries... | Denise M. Dignam | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Aug 2023 | 380 | 380 (0%) | 0% | 0 | Common Stock |